“Recombinant Nanobiotechnology for Swallowable Insulin: Innovations in Noninvasive Diabetes Therapy: Recombinant Oral Insulin Nanobiotechnology” (2025) Ricos Biology, 3(11), pp. 15–19. doi:10.33687/ricosbiol.03.011.90.